Discussion in 'Phoenix Rising Articles' started by Firestormm, Dec 6, 2013.
It would have paid for the Rituximab study.
Thankyou MeSCI. The details say:
l wonder which so-called treaments they refer to, as useless GET and CBT are the only treatments offered to myalgic encephalomyelitis sufferers in the UK. Then again, as they will probably use the Oxford criteria that Prof White, I understand helped develop, goodness knows what medical condition will be studied.
The grant proposal says they should be receiving "specialist treatment" and already be diagnosed hence they should be NHS diagnostic guidelines. To my knowledge they have not been subjected to external validation as per Canadian and Fukuda but PEM is present. What concerns me more is the time period, many ME patients improve over summer thus perverting results. Also this is not 'placebo controlled' since they are comparing with an obvious lack of treatment.
[above content edited to reflect a correction from Firestorm]
NICE Guideline states:
Corrected with thanks.
You can also try a Google Site Search
Separate names with a comma.